Showing results (121-130 of 721) with videos related to

Sort By:
Pageof 73
Journal of Medical Economics|October 7, 2025
Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's disease (aPD): demonstration of savings from a societal perspective in the UKK Ray Chaudhuri, Lars Bergmann, Jonathan Belsey, et al.
International Review of Neurobiology|August 14, 2017
Nonmotor Subtyping in Parkinson's DiseaseAnna Sauerbier, Miguel Rosa-Grilo, Mubasher A Qamar, et al.
Current Neuropharmacology|August 1, 2023
Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson's DiseaseDaniel J van Wamelen, Valentina Leta, K Ray Chaudhuri, et al.
Journal of Parkinson'S Disease|December 26, 2018
Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson's DiseaseDaniel J van Wamelen, Sotirios Grigoriou, K Ray Chaudhuri, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 29, 2016
Parkinson's: a syndrome rather than a disease?Nataliya Titova, C Padmakumar, Simon J G Lewis, et al.
Neurology and Therapy|June 14, 2024
Subcutaneous Levodopa: A New Engine for the Vintage MoleculeKarolina Poplawska-Domaszewicz, Lucia Batzu, Cristian Falup-Pecurariu, et al.
Parkinsonism & Related Disorders|December 13, 2016
The efficacy of apomorphine - A non-motor perspectiveMiguel Rosa-Grilo, Mubasher A Qamar, Andrew Evans, et al.
Expert Review of Neurotherapeutics|January 8, 2025
The complexities in the differential diagnosis of restless legs syndrome (Willis-Ekbom disease)Karolina Poplawska-Domaszewicz, Silvia Rota, Mubasher A Qamar, et al.
Journal of Medical Economics|September 10, 2024
Foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson's Disease (aPD): demonstration of savings from a societal perspective in the UKK Ray Chaudhuri, Lars Bergmann, Jonathan Belsey, et al.
Pageof 73